Invention Grant
- Patent Title: Dosage and formulation
-
Application No.: US13692032Application Date: 2012-12-03
-
Publication No.: US10085974B2Publication Date: 2018-10-02
- Inventor: Rosa Lamarca Casado , Gonzalo De Miquel Serra
- Applicant: Almirall, S.A.
- Applicant Address: ES Barcelona
- Assignee: Almirall, S.A.
- Current Assignee: Almirall, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: EP08382010 20080313
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61K45/06 ; A61K9/00 ; A61K31/167 ; A61K31/46
Abstract:
The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.
Public/Granted literature
- US20130189317A1 NOVEL DOSAGE AND FORMULATION Public/Granted day:2013-07-25
Information query
IPC分类:
